Literature DB >> 10193323

Increased sialylation of oligosaccharides on IgG paraproteins--a potential new tumour marker in multiple myeloma.

S C Fleming1, S Smith, D Knowles, A Skillen, C H Self.   

Abstract

AIMS: To investigate whether changes in carbohydrate structure of IgG are related to malignancy and stage of disease in myeloma and monoclonal gammopathy of uncertain significance (MGUS).
METHODS: 61 patients were studied at diagnosis: 14 with MGUS, nine with stage I multiple myeloma, 11 with stage II, 21 with stage III, and five with solitary plasmacytoma. IgG was extracted from serum by protein G affinity chromatography. Oligosaccharides were cleaved from the protein backbone enzymatically by N-glycosidase F. Oligosaccharide analysis was performed by high pressure anion exchange chromatography with pulsed electrochemical detection (HPAE-PED).
RESULTS: Up to 15 oligosaccharide peaks were identified in three major fractions: neutral, monosialylated, and disialylated. Patients with myeloma showed an increase in the proportion of sialylated oligosaccharides in comparison with patients with MGUS. The ratio of neutral to sialylated oligosaccharides (N:S) was reduced at all stages of myeloma compared with MGUS: MGUS, 11.35; myeloma stage I, 7.6 (p = 0.047); stage II, 5.20 (p = 0.035); stage III, 3.60 (p = 0.0002); plasmacytoma, 7.5 (p = 0.046). The N:S ratio was independent of paraprotein concentration (r = 0.05).
CONCLUSIONS: The ratio of neutral to sialylated oligosaccharides may act as a new marker of malignancy in IgG paraproteinaemia and warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10193323      PMCID: PMC500976          DOI: 10.1136/jcp.51.11.825

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  30 in total

1.  THE CARBOHYDRATE PROSTHETIC GROUP OF HUMAN GAMMA-GLOBULIN.

Authors:  J R CLAMP; F W PUTNAM
Journal:  J Biol Chem       Date:  1964-10       Impact factor: 5.157

2.  Frequency of pathological proteins (M-components) om 6,995 sera from an adult population.

Authors:  U Axelsson; R Bachmann; J Hällén
Journal:  Acta Med Scand       Date:  1966-02

Review 3.  Staging and kinetics of multiple myeloma.

Authors:  B G Durie
Journal:  Semin Oncol       Date:  1986-09       Impact factor: 4.929

4.  Hydrazinolysis of asparagine-linked sugar chains to produce free oligosaccharides.

Authors:  S Takasaki; T Mizuochi; A Kobata
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

5.  Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines.

Authors:  G Yogeeswaran; P L Salk
Journal:  Science       Date:  1981-06-26       Impact factor: 47.728

6.  Serum sialyltransferase and fucosyltransferase activities in patients with multiple myeloma.

Authors:  G Frithz; G Ronquist; P Ericsson
Journal:  Eur J Cancer Clin Oncol       Date:  1985-08

7.  Different patterns of lectin binding and cell surface sialylation detected on related high- and low-metastatic tumor lines.

Authors:  P Altevogt; M Fogel; R Cheingsong-Popov; J Dennis; P Robinson; V Schirrmacher
Journal:  Cancer Res       Date:  1983-11       Impact factor: 12.701

8.  Primary structure of the N-glycosidically linked sialoglycans of secretory immunoglobulins A from human milk.

Authors:  A Pierce-Cretel; M Pamblanco; G Strecker; J Montreuil; G Spik; L Dorland; H Van Halbeek; J F Vliegenthart
Journal:  Eur J Biochem       Date:  1982-07

9.  Major carbohydrate structures at five glycosylation sites on murine IgM determined by high resolution 1H-NMR spectroscopy.

Authors:  D R Anderson; P H Atkinson; W J Grimes
Journal:  Arch Biochem Biophys       Date:  1985-12       Impact factor: 4.013

10.  Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG.

Authors:  R B Parekh; R A Dwek; B J Sutton; D L Fernandes; A Leung; D Stanworth; T W Rademacher; T Mizuochi; T Taniguchi; K Matsuta
Journal:  Nature       Date:  1985 Aug 1-7       Impact factor: 49.962

View more
  9 in total

Review 1.  Serum sialylation changes in cancer.

Authors:  Zejian Zhang; Manfred Wuhrer; Stephanie Holst
Journal:  Glycoconj J       Date:  2018-04-21       Impact factor: 2.916

Review 2.  Sialic acids: biomarkers in endocrinal cancers.

Authors:  Shyamasree Ghosh
Journal:  Glycoconj J       Date:  2015-03-17       Impact factor: 2.916

3.  Proteomics-inspired precision medicine for treating and understanding multiple myeloma.

Authors:  Matthew Ho; Giada Bianchi; Kenneth C Anderson
Journal:  Expert Rev Precis Med Drug Dev       Date:  2020-02-24

4.  Glycosylation of IgG B cell receptor (IgG BCR) in multiple myeloma: relationship between sialylation and the signal activity of IgG BCR.

Authors:  Vesna Ilić; Nadezda Milosević-Jovcić; Sonja Petrović; Dragana Marković; Gordana Stefanović; Tatjana Ristić
Journal:  Glycoconj J       Date:  2008-01-11       Impact factor: 2.916

5.  Glycosylation of plasma IgG in colorectal cancer prognosis.

Authors:  Evropi Theodoratou; Kujtim Thaçi; Felix Agakov; Maria N Timofeeva; Jerko Štambuk; Maja Pučić-Baković; Frano Vučković; Peter Orchard; Anna Agakova; Farhat V N Din; Ewan Brown; Pauline M Rudd; Susan M Farrington; Malcolm G Dunlop; Harry Campbell; Gordan Lauc
Journal:  Sci Rep       Date:  2016-06-15       Impact factor: 4.379

6.  Pro-inflammatory State in Monoclonal Gammopathy of Undetermined Significance and in Multiple Myeloma Is Characterized by Low Sialylation of Pathogen-Specific and Other Monoclonal Immunoglobulins.

Authors:  Adrien Bosseboeuf; Sophie Allain-Maillet; Nicolas Mennesson; Anne Tallet; Cédric Rossi; Laurent Garderet; Denis Caillot; Philippe Moreau; Eric Piver; François Girodon; Hélène Perreault; Sophie Brouard; Arnaud Nicot; Edith Bigot-Corbel; Sylvie Hermouet; Jean Harb
Journal:  Front Immunol       Date:  2017-10-19       Impact factor: 7.561

Review 7.  Sialylation is involved in cell fate decision during development, reprogramming and cancer progression.

Authors:  Fenjie Li; Junjun Ding
Journal:  Protein Cell       Date:  2018-11-26       Impact factor: 14.870

Review 8.  Sialylated Immunoglobulins for the Treatment of Immuno-Inflammatory Diseases.

Authors:  Yuliya V Markina; Elena V Gerasimova; Alexander M Markin; Victor Y Glanz; Wei-Kai Wu; Igor A Sobenin; Alexander N Orekhov
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

9.  Glycation Interferes with the Expression of Sialyltransferases in Meningiomas.

Authors:  Philipp Selke; Kaya Bork; Tao Zhang; Manfred Wuhrer; Christian Strauss; Rüdiger Horstkorte; Maximilian Scheer
Journal:  Cells       Date:  2021-11-25       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.